Metastatic prostate cancer study now enrolling.
You’re fighting back. We’re working to enhance your body’s ability to do the same. The PROSPECT study is evaluating potential effectiveness of an investigational vaccine-based immunotherapy for metastatic prostate cancer. The investigational vaccine- administered through a series of injections over a period of five months- is designed to teach the body’s immune system to identify and destroy prostate cancer cell.
To learn more about available clinical trials, please contact the office listed below: